Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals

Detalles Bibliográficos
Autores principales: Ntanasis-Stathopoulos, Ioannis, Karalis, Vangelis, Sklirou, Aimilia D., Gavriatopoulou, Maria, Alexopoulos, Harry, Malandrakis, Panagiotis, Trougakos, Ioannis P., Dimopoulos, Meletios A., Terpos, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263459/
https://www.ncbi.nlm.nih.gov/pubmed/35813098
http://dx.doi.org/10.1097/HS9.0000000000000747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263459/
https://www.ncbi.nlm.nih.gov/pubmed/35813098
http://dx.doi.org/10.1097/HS9.0000000000000747

Ejemplares similares